Bishop, N. et al. (2013) Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet, 382(9902), pp. 1424-1432. (doi: 10.1016/S0140-6736(13)61091-0)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1016/S0140-6736(13)61091-0
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Ahmed, Professor Syed Faisal |
Authors: | Bishop, N., Adami, S., Ahmed, S.F., Anton, J., Arundel, P., Burren, C.P., Devogelaer, J.-P., Hangartner, T., Hosszu, E., Lane, J.M., Lorenc, R., Makitie, O., Munns, C.F., Paredes, A., Pavlov, H., Plotkin, H., Raggio, C.L., Reyes, M.L., Schoenau, E., Semler, O., Sillence, D.O., and Steiner, R.D. |
College/School: | College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
Journal Name: | Lancet |
Publisher: | The Lancet Publishing Group |
ISSN: | 0140-6736 |
University Staff: Request a correction | Enlighten Editors: Update this record